Penumbra (PEN) Other Non-Current Assets (2014 - 2026)
Penumbra (PEN) reported Other Non-Current Assets of $41.0 million for Q1 2026, down 6.28% year-over-year from $43.7 million in Q1 2025, and up 0.66% quarter-over-quarter from $40.7 million in Q4 2025.
Penumbra (PEN) Other Non-Current Assets (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Other Non-Current Assets data on file, last reported at $41.0 million in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $41.0 million, down 6.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $41.0 million (down 6.28% YoY), and the FY2025 annual result was $40.7 million, down 0.54% from the prior year.
- Other Non-Current Assets rose to $41.0 million in Q1 2026 per PEN's latest filing, from $40.7 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $43.7 million in Q1 2025 and troughed at $10.5 million in Q2 2023.
- A 5-year average of $27.9 million and a median of $33.8 million in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets decreased 24.84% in 2023, then jumped 266.84% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $12.8 million in 2022, then soared by 102.3% to $25.9 million in 2023, then surged by 58.19% to $40.9 million in 2024, then retreated by 0.54% to $40.7 million in 2025, then advanced by 0.66% to $41.0 million in 2026.
- Business Quant data shows PEN's Other Non-Current Assets at $41.0 million in Q1 2026, $40.7 million in Q4 2025, and $40.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 738.90 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 2.25 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 285.90 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | 40.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.98 Mn |
| Dec 31, 2025 | 40.72 Mn |
| Sep 30, 2025 | 40.02 Mn |
| Jun 30, 2025 | 40.39 Mn |
| Mar 31, 2025 | 43.73 Mn |
| Dec 31, 2024 | 40.94 Mn |
| Sep 30, 2024 | 38.51 Mn |
| Jun 30, 2024 | 38.52 Mn |
| Mar 31, 2024 | 33.81 Mn |
| Dec 31, 2023 | 25.88 Mn |
| Sep 30, 2023 | 14.74 Mn |
| Jun 30, 2023 | 10.50 Mn |
| Mar 31, 2023 | 11.17 Mn |
| Dec 31, 2022 | 12.79 Mn |
| Sep 30, 2022 | 13.48 Mn |
| Jun 30, 2022 | 13.97 Mn |
| Mar 31, 2022 | 13.69 Mn |
| Dec 31, 2021 | 12.99 Mn |
| Sep 30, 2021 | 11.37 Mn |
| Mar 31, 2021 | 9.91 Mn |